MVP Development for Pharmaceuticals & Life Sciences

We write down what was deliberately excluded. Unstated exclusions become assumed inclusions, and that is where founder-developer relationships go wrong.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how mvp development has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is literature monitoring, usually integrated against LIMS. We start from the constraint, not the capability, what the system must never do, who signs off, and what happens when it is wrong.

Built by engineers who ship production systems, not by a practice that subcontracts the build. You own the code, the models where they are open-weight, and the documentation to run it without us.